observed a high frequency of promoter hypermethylation and progressive loss of GPx3 expression in Barretts esophagus and its associated lesions, and these authors also confirmed the known function of GPx3 as a potent antioxidant [54]
A 30-day supply of the injectables Zepbound (tirzepatide) and Wegovy (semaglutide) has a list price of roughly $1,000 per month
Several mechanisms might explain possible benefits: Improved glycaemic control : Better blood glucose regulation may reduce endothelial dysfunction and microvascular damage, both implicated in ED pathophysiology Weight reduction : Significant weight loss can improve testosterone levels, reduce inflammation, and enhance vascular function Cardiovascular effects : GLP-1 agents may improve endothelial function and reduce cardiovascular risk factors that contribute to ED Reduced inflammation : These medications have been associated with anti-inflammatory effects that might benefit vascular health, though more research is needed Some observational studies have reported improvements in erectile function scores among men with diabetes treated with GLP-1 receptor agonists, though the evidence is limited and more robust research is needed
Tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight management, activates two hormone pathways to reduce appetite and regulate blood sugar
The STEP 4 Evidence STEP 4 directly examined discontinuation